|
1
|
Maluccio M and Covey A: Recent progress in
understanding, diagnosing, and treating hepatocellular carcinoma.
CA Cancer J Clin. 62:394–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bhayani NH, Jiang Y, Hamed O, Kimchi ET,
Staveley-O'Carroll KF and Gusani NJ: Advances in the pharmacologic
treatment of hepatocellular carcinoma. Curr Clin Pharmacol.
10:299–304. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moeini A, Cornellà H and Villanueva A:
Emerging signaling pathways in hepatocellular carcinoma. Liver
Cancer. 1:83–93. 2012. View Article : Google Scholar
|
|
4
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
6
|
Fang W and Bartel DP: The menu of features
that define primary microRNAs and enable de novo design of dicroRNA
genes. Mol Cell. 60:131–145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Parpart S, Roessler S, Dong F, Rao V,
Takai A, Ji J, Qin LX, Ye QH, Jia HL, Tang ZY and Wang XW:
Modulation of miR-29 expression by α-fetoprotein is linked to the
hepatocellular carcinoma epigenome. Hepatology. 60:872–883. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Najafi Z, Sharifi M and Javadi G:
Degradation of miR-21 induces apoptosis and inhibits cell
proliferation in human hepatocellular carcinoma. Cancer Gene Ther.
22:530–535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He XX, Guo AY, Xu CR, Chang Y, Xiang GY,
Gong J, Dan ZL, Tian DA, Liao JZ and Lin JS: Bioinformatics
analysis identifies miR-221 as a core regulator in hepatocellular
carcinoma and its silencing suppresses tumor properties. Oncol Rep.
32:1200–1210. 2014.PubMed/NCBI
|
|
10
|
Yang X, Liang L, Zhang XF, Jia HL, Qin Y,
Zhu XC, Gao XM, Qiao P, Zheng Y, Sheng YY, et al: MicroRNA-26a
suppresses tumor growth and metastasis of human hepatocellular
carcinoma by targeting interleukin-6-Stat3 pathway. Hepatology.
58:158–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baek S, Cho KJ, Ju HL, Moon H, Choi SH,
Chung SI, Park JY, Choi KH, Kim Y, Ahn SH, et al: Analysis of miRNA
expression patterns in human and mouse hepatocellular carcinoma
cells. Hepatol Res. 45:1331–1340. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mlcochova J, Faltejskova-Vychytilova P,
Ferracin M, Zagatti B, Radova L, Svoboda M, Nemecek R, John S, Kiss
I, Vyzula R, et al: MicroRNA expression profiling identifies
miR-31-5p/3p as associated with time to progression in wild-type
RAS metastatic colorectal cancer treated with cetuximab.
Oncotarget. 6:38695–38704. 2015.PubMed/NCBI
|
|
13
|
Tseng SH, Yang CC, Yu EH, Chang C, Lee YS,
Liu CJ, Chang KW and Lin SC: K14-EGFP-miR-31 transgenic mice have
high susceptibility to chemical-induced squamous cell tumorigenesis
that is associating with Ku80 repression. Int J Cancer.
136:1263–1275. 2015. View Article : Google Scholar
|
|
14
|
Lu WC, Liu CJ, Tu HF, Chung YT, Yang CC,
Kao SY, Chang KW and Lin SC: miR-31 targets ARID1A and enhances the
oncogenicity and stemness of head and neck squamous cell carcinoma.
Oncotarget. Aug 9–2016.Epub ahead of print.
|
|
15
|
Gao W, Liu L, Xu J, Shao Q, Liu Y, Zeng H
and Shu Y: A systematic analysis of predicted MiR-31-targets
identifies a diagnostic and prognostic signature for lung cancer.
Biomed Pharmacother. 68:419–427. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Taccioli C, Garofalo M, Chen H, Jiang Y,
Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley
KJ, et al: Repression of esophageal neoplasia and inflammatory
signaling by anti-miR-31 delivery in vivo. J Natl Cancer Inst.
107:djv2202015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang S, Li Q, Wang K, Dai Y, Yang J, Xue
S, Han F, Zhang Q, Liu J and Wu W: Decreased expression of
microRNA-31 associates with aggressive tumor progression and poor
prognosis in patients with bladder cancer. Clin Transl Oncol.
15:849–854. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schaefer A, Jung M, Mollenkopf HJ, Wagner
I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G and Jung
K: Diagnostic and prognostic implications of microRNA profiling in
prostate carcinoma. Int J Cancer. 126:1166–1176. 2010.
|
|
19
|
Ruoming W, Zhen Y, Tengteng Z and Jisheng
H: Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by
targeting Smad4 and SGPP2. Cancer Gene Ther. 22:564–572. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HS, Lee KS, Bae HJ, Eun JW, Shen Q,
Park SJ, Shin WC, Yang HD, Park M, Park WS, et al: MicroRNA-31
functions as a tumor suppressor by regulating cell cycle and
epithelial-mesenchymal transition regulatory proteins in liver
cancer. Oncotarget. 6:8089–8102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Viré E, Curtis C, Davalos V, Git A, Robson
S, Villanueva A, Vidal A, Barbieri I, Aparicio S, Esteller M, et
al: The breast cancer oncogene EMSY represses transcription of
antimetastatic microRNA miR-31. Mol Cell. 53:806–818. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Creighton CJ, Fountain MD, Yu Z, Nagaraja
AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM and
Anderson ML: Molecular profiling uncovers a p53-associated role for
microRNA-31 in inhibiting the proliferation of serous ovarian
carcinomas and other cancers. Cancer Res. 70:1906–1915. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang N, Zhang J, Shuai L, Zha L, He M,
Huang Z and Wang Z: Krüppel-like factor 4 negatively regulates
β-catenin expression and inhibits the proliferation, invasion and
metastasis of gastric cancer. Int J Oncol. 40:2038–2048.
2012.PubMed/NCBI
|
|
24
|
Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z,
Le X, Wei D, Huang S and Xie K: Dysregulated Krüppel-like factor 4
and vitamin D receptor signaling contribute to progression of
hepatocellular carcinoma. Gastroenterology. 143:799–810.e1. 22012.
View Article : Google Scholar
|
|
25
|
Yu T, Chen X, Lin T, Liu J, Li M, Zhang W,
Xu X, Zhao W, Liu M, Napier DL, et al: KLF4 deletion alters gastric
cell lineage and induces MUC2 expression. Cell Death Dis.
7:e22552016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv H, Zhang Z, Wang Y, Li C, Gong W and
Wang X: MicroRNA-92a promotes colorectal cancer cell growth and
migration by inhibiting KLF4. Oncol Res. 23:283–290. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu S, Yang H, Chen Y, He B and Chen Q:
Krüppel-like factor 4 enhances sensitivity of cisplatin to lung
cancer cells and inhibits regulating epithelial-to-mMesenchymal
transition. Oncol Res. 24:81–87. 2016. View Article : Google Scholar
|
|
28
|
Gandellini P, Giovannetti E and Nicassio
F: MicroRNAs in cancer management: Big challenges for small
molecules. Biomed Res Int. 2015:9821562015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou J, Lai PB and Tsui SK: Identification
of a non-coding KLF4 transcript generated from intron retention and
downregulated in human hepatocellular carcinoma. Int J Oncol.
47:1554–1562. 2015.PubMed/NCBI
|
|
30
|
Tien YT, Chang MH, Chu PY, Lin CS, Liu CH
and Liao AT: Downregulation of the KLF4 transcription factor
inhibits the proliferation and migration of canine mammary tumor
cells. Vet J. 205:244–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mao Q, Quan T, Luo B, Guo X, Liu L and
Zheng Q: MiR-375 targets Klf4 and impacts the proliferation of
colorectal carcinoma. Tumour Biol. 37:463–471. 2016. View Article : Google Scholar
|
|
32
|
Lin ZS, Chu HC, Yen YC, Lewis BC and Chen
YW: Krüppel-like factor 4, a tumor suppressor in hepatocellular
carcinoma cells reverts epithelial mesenchymal transition by
suppressing slug expression. PLoS One. 7. pp. e435932012,
View Article : Google Scholar
|
|
33
|
Fiorenza A, Lopez-Atalaya JP, Rovira V,
Scandaglia M, Geijo-Barrientos E and Barco A: Blocking miRNA
biogenesis in adult forebrain neurons enhances seizure
susceptibility, fear memory, and food intake by increasing neuronal
responsiveness. Cereb Cortex. 26:1619–1633. 2016. View Article : Google Scholar
|
|
34
|
Meehan K and Vella LJ: The contribution of
tumour-derived exosomes to the hallmarks of cancer. Crit Rev Clin
Lab Sci. 53:121–131. 2016. View Article : Google Scholar
|
|
35
|
Yang F, Yin Y, Wang F, Wang Y, Zhang L,
Tang Y and Sun S: miR-17-5p Promotes migration of human
hepatocellular carcinoma cells through the p38 mitogen-activated
protein kinase-heat shock protein 27 pathway. Hepatology.
51:1614–1623. 2010. View Article : Google Scholar : PubMed/NCBI
|
